[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340453-105":59,"doc-detail-340453-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prostate-specific-antigen-testing-patterns-and-prostate-cancer-stage-at-diagnosis-in-older-ohio-cancer-patients","Prostate-specific antigen testing patterns and prostate cancer stage at diagnosis in older Ohio cancer patients","","Prostate cancer screening guidance does not endorse PSA screening for older men, yet real-world practice often includes such testing. Using linked Ohio Cancer Incidence Surveillance System data and Medicare records, men aged 68+ with prostate cancer were classified by PSA testing as screening or diagnostic within the three years before diagnosis. Multivariable logistic regression evaluated factors associated with screening PSA and its independent relationship to distant stage disease.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prostate-specific-antigen-testing-patterns-and-prostate-cancer-stage-at-diagnosis-in-older-ohio-cancer-patients/340453/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prostate-specific-antigen-testing-patterns-and-prostate-cancer-stage-at-diagnosis-in-older-ohio-cancer-patients/340453.png","ImageObject",300,407,{"name":92,"@type":93},"Seraphina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How were PSA tests classified as screening versus diagnostic in the study?","Question",{"text":112,"@type":113},"PSA testing in the three years preceding diagnosis was categorized as screening or diagnostic based on the study design using linked Ohio Cancer Incidence Surveillance System and Medicare data.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What factors were associated with lower screening-based PSA use?",{"text":117,"@type":113},"Older age (75–84 and ≥85) and frailty were associated with lower odds of screening-based PSA testing.",{"name":119,"@type":110,"acceptedAnswer":120},"Did screening-based PSA testing relate to the stage at diagnosis?",{"text":121,"@type":113},"Screening-based PSA was associated with decreased odds of distant stage disease, while older age, frailty, and being separated or divorced were associated with increased distant stage prostate cancer.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340453,1790716944,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","Cancer Causes & Control (2024) 35:1531–1540 [https://doi.org/10.1007/s10552-024-01908-x](https://doi.org/10.1007/s10552-024-01908-x)  \nProstate‑specific antigen testing patterns and prostate cancer stage at diagnosis in older Ohio cancer patients  \nSajan N. Patel1 · Long Vu1 · Holly E. Hartman1,2 · Weichuan Dong1 · Siran M. Koroukian1,2 · Johnie Rose1,2,3  \nReceived: 25 March 2024 / Accepted: 14 August 2024 / Published online: 3 September 2024 © The Author(s) 2024  \nAbstract  \nBackground Prostate cancer (PCa) screening recommendations do not support prostate-specific antigen (PSA) screening for older men. Such screening often occurs, however. It is, therefore, important to understand how frequently and among which subgroups screening occurs, and the extent of distant stage PCa diagnoses among screened older men.  \nMethods Using the 2014–2016 linked Ohio Cancer Incidence Surveillance System (OCISS) and Medicare administrative database, we identified men 68 and older diagnosed with PCa and categorized their PSA testing in the three years preceding diagnosis as screening or diagnostic. We conducted multivariable logistic regression analysis to identify correlates of screening PSA and to determine whether screening PSA is independently associated with distant stage disease.  \nResults Our study population included 3034 patients (median age: 73 years). 62.1% of PCa patients underwent at least one screening-based PSA in the three years preceding diagnosis. Older age (75–84 years: aOR [95% CI]: 0.84 [0.71, 0.99], ≥ 85: aOR: 0.27 [0.19, 0.38]), and frailty (aOR: 0.51 [0.37, 0.71]) were associated with lower screening. Screening was associated with decreased odds of distant stage disease (aOR: 0.55 [0.42, 0.71]) . However, older age (75–84 years: aOR: 2.43 [1.82, 3.25], ≥ 85: aOR: 10.57 [7.05, 15.85]), frailty (aOR: 5.00 [2.78, 9.31]), and being separated or divorced (aOR: 1.64 [1.01, 2.60]) were associated with increased distant stage PCa.  \nConclusion PSA screening in older men is common, though providers appear to curtail PSA screening as age and frailty increase. Screened older men are diagnosed at earlier stages, but the harms of screening cannot be assessed.  \nKeywords Prostate-specific antigen testing · Screening · Diagnostic testing · Prostate cancer · Frailty  \nPresentations Public Health Innovations Conference (April 21, 2023), Case Comprehensive Cancer Center Annual Scientific Retreat (July 20, 2023), 16th American Association for Cancer Research on The Science of Cancer Disparities in Racial/Ethnic Minorities and the Medically Underserved (October 1, 2023), and Graduate and School of Medicine Research Day (December 7, 2023) .  \n* Johnie Rose [jxr109@case.edu](jxr109@case.edu)  \n[Sajan N. Patel](Sajan N. Patel)[ ](Sajan N. Patel)[snp52@case.edu](snp52@case.edu)  \nLong Vu  \n[lxv61@case.edu](lxv61@case.edu)  \nHolly E. Hartman [heh39@case.edu](heh39@case.edu)  \nWeichuan Dong [wxd149@case.edu](wxd149@case.edu)  \nIntroduction  \nProstate cancer (PCa) is the second most common cancer among the United States men [1] . Although the incidence of PCa has remained stable over the past decade, the percentage of PCa cases diagnosed at a distant stage has increased from 3.9 to 8.2% over the same time span [2] . Elevated ProstateSpecific Antigen (PSA) level is a relatively sensitive, although  \nSiran M. Koroukian  \n[sxk15@case.edu](sxk15@case.edu)  \n1 Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA  \n2 Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA  \n3 Center for Community Health Integration, Case Western Reserve University School of Medicine, Cleveland, OH, USA  \nFig. 1 Flowchart showing patient selection for study population  \nnot highly specific, marker of PCa [3]. When prostate-specific antigen (PSA) levels are abnormally high, further testing, such as a biopsy, may be necessary to ascertain PCa diag","cbCaihLIFdAX9Obv","https://ap.wps.com/l/cbCaihLIFdAX9Obv","pdf",839536,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Keywords and Presentations\n# Introduction","[{\"question\":\"How were PSA tests classified as screening versus diagnostic in the study?\",\"answer\":\"PSA testing in the three years preceding diagnosis was categorized as screening or diagnostic based on the study design using linked Ohio Cancer Incidence Surveillance System and Medicare data.\"},{\"question\":\"What factors were associated with lower screening-based PSA use?\",\"answer\":\"Older age (75–84 and ≥85) and frailty were associated with lower odds of screening-based PSA testing.\"},{\"question\":\"Did screening-based PSA testing relate to the stage at diagnosis?\",\"answer\":\"Screening-based PSA was associated with decreased odds of distant stage disease, while older age, frailty, and being separated or divorced were associated with increased distant stage prostate cancer.\"}]","Prostate-specific antigen testing patterns and prostate cancer stage at diagnosis in older Ohio cancer patients | PDF",1790036629,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cc30c029e3173bf4f5a7e60d4f6827c9.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a29f1beaa1e5e1badbc0e15fe5aed40.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8f2289b3cf696e9530924331f38f27f3.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9745b55c9deaa55b9e8619f2a9694932.webp",980,1301]